Friday, December 10, 2021

Myeloma Patients: Landmark Study Validated as Unparalleled in Cancer Research

Today, the Multiple Myeloma Research Foundation (MMRF) announced that new insights related to novel targets, risk assessment, and precision medicine approaches generated through the use of the MMRF landmark CoMMpass Study will be presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. In total, ASH will feature 33 presentations developed through the work of more than 200 researchers from 180 institutions all using the CoMMpass data. - eTurboNews | Trends | Travel News
http://dlvr.it/SF91vB

No comments:

Post a Comment